Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
43.3M
-
Shares change
-
+1.99M
-
Total reported value, excl. options
-
$215M
-
Value change
-
+$8.63M
-
Put/Call ratio
-
1.09
-
Number of buys
-
56
-
Number of sells
-
-62
-
Price
-
$4.95
Significant Holders of OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) as of Q1 2022
158 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - COMMON STOCK as of Q1 2022.
OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.3M shares
of 159M outstanding shares and own 27.19% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (5.97M shares), SUMMER ROAD LLC (5.94M shares), BlackRock Inc. (5.07M shares), VANGUARD GROUP INC (4.2M shares), DELTEC ASSET MANAGEMENT LLC (2.08M shares), STATE STREET CORP (1.7M shares), CITADEL ADVISORS LLC (1.69M shares), GEODE CAPITAL MANAGEMENT, LLC (1.36M shares), EMERALD ADVISERS, LLC (1.29M shares), and EMERALD MUTUAL FUND ADVISERS TRUST (1.09M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.